NPI: 1831477173 · JACKSONVILLE, FL 32216 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/03/2011
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 08/03/2011 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,250 | $533K |
| 2019 | 15,240 | $1.05M |
| 2020 | 19,047 | $2.78M |
| 2021 | 14,792 | $1.17M |
| 2022 | 13,920 | $1.44M |
| 2023 | 7,331 | $712K |
| 2024 | 1,962 | $131K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,790 | 2,140 | $3.04M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,488 | 1,109 | $2.07M |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,352 | 825 | $1.10M |
| A4657 | Syringe, with or without needle, each | 3,206 | 1,255 | $653K |
| J1756 | Injection, iron sucrose, 1 mg | 5,711 | 1,018 | $511K |
| 85041 | 1,368 | 845 | $117K | |
| 85048 | 1,263 | 771 | $104K | |
| 83970 | 741 | 489 | $83K | |
| 82728 | 491 | 331 | $46K | |
| 83540 | 482 | 321 | $43K | |
| 83550 | 465 | 308 | $41K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 155 | 78 | $12K |
| 82108 | 15 | 13 | $1K | |
| G0008 | Administration of influenza virus vaccine | 15 | 12 | $949.78 |